In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Tom Willgoss, Patient-Centered Outcomes Research Chapter Lead, UK Site Head for Data Sciences at Roche to discuss the value of understanding and measuring patient experience data throughout the clinical journey. They delve into the significance of patient-centered clinical outcome assessments for endpoint selection in clinical trials, prioritizing diversity and inclusion across global clinical sites with the help of translation services providers, and shifting trends towards DCTs.
Tune in to our chat with Aaron McCormick, Associate Director, eCOA Implementation at Moderna, to unravel the importance of standardized eCOA systems across trials...
DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host...
In this episode of LifeSci Talks, TransPerfect’s Global Practice Leader Mark Wade sits down with Dr. Karl McEvoy, VP of eCOA and Patient Technology...
